The carbon storage regulator gene, csrA, encodes a factor which negatively modulates the expression of the glycogen biosynthetic gene glgC by enhancing the decay of its mRNA (M. Y. Liu, H. Yang, and T. Romeo, J. Bacteriol. 177:2663-2672, 1995). When endogenous glycogen levels in isogenic csrA ؉ and csrA::kanR strains were quantified during the growth curve, both the rate of glycogen accumulation during late exponential or early stationary phase and its subsequent rate of degradation were found to be greatly accelerated by the csrA::kanR mutation. The expression of the biosynthetic genes glgA (glycogen synthase) and glgS was observed to be negatively modulated via csrA. Thus, csrA is now known to control all of the known glycogen biosynthetic genes (glg), which are located in three different operons. Similarly, the expression of the degradative enzyme glycogen phosphorylase, which is encoded by glgY, was found to be negatively regulated via csrA in vivo. The in vitro transcription-translation of glgY was also specifically inhibited by the purified CsrA gene product. These results demonstrate that localization of glycogen biosynthetic and degradative genes within the Escherichia coli glgCAY operon facilitates their coordinate genetic regulation, as previously hypothesized (T. Romeo, A. Kumar, and J. Preiss, Gene 70:363-376, 1988). The csrA gene did not affect glycogen debranching enzyme, which is now shown to be encoded by the gene glgX.
One feature of the complex adaptive response which occurs when Escherichia coli or various other bacteria enter stationary phase is the increased expression of genes involved in the biosynthesis of glycogen (reviewed in references 12 and 20-22) . A shortage of a nutrient such as nitrogen in the presence of excess carbon is particularly effective in causing the intracellular accumulation of glycogen, which can be metabolized as an endogenous carbon and energy source. The regulatory mechanisms for glycogen synthesis in E. coli include (i) allosteric control via the metabolites AMP and fructose-1,6-bisphosphate of the committed step of the pathway, catalyzed by ADPglucose pyrophosphorylase (EC 2.7.7.27); (ii) stimulation of the genetic expression of glgC (which encodes ADPglucose pyrophosphorylase [2] ) and glgA (which encodes glycogen synthase [EC 2.4.1.21] [13] ) by guanosine 3Ј-bisphosphate 5Ј-bisphosphate and cyclic AMP (cAMP); and (iii) the transcriptional control of glgS, a monocistronic gene which stimulates glycogen synthesis in vivo, by cAMP and s (9, 20-22, 24, 28) . We recently identified and characterized the csrA gene, which exerts a very strong negative effect on glycogen synthesis in E. coli (25, 26) . This gene encodes a 61-amino-acid protein, CsrA, which was shown to regulate the expression of glgB (encoding glycogen branching enzyme [EC 2.4.1.18]) and glgC (26) . CsrA has been shown to be a factor which enhances the rate of decay of glgC mRNA via a novel though unresolved mechanism (16) . The deduced amino acid sequence of CsrA is homologous to a diverse subset of RNA-binding proteins, the KH proteins (16) . The csrA gene was originally shown to have pleiotropic effects on gluconeogenesis and cell surface properties (26) , and we have more recently confirmed that csrA negatively regulates gluconeogenesis and also positively regulates glycolysis in E. coli (29) . The involvement of the csrA homolog of Erwinia carotovora (rsmA, for repressor of stationary-phase metabolites) in the negative regulation of several virulence factors which cause soft-rot disease of plants and its widespread occurrence among members of the family Enterobacteriaceae (7) provide further evidence of the important role which csrA plays in the regulation of bacterial physiology and metabolism. The finding of an apparent homolog of csrA in Haemophilus influenzae during the whole-genome sequencing project (8) and our own unpublished hybridization data (35) indicate that csrA is present in members of several families of gram-negative bacteria.
The regulation and molecular genetics of endogenous glycogen degradation in E. coli have yet to be thoroughly investigated. However, a key enzyme in glycogen metabolism, glycogen phosphorylase (EC 2.4.1.1), is known to be allosterically inhibited by ADPglucose and activated by AMP (5). Glycogen phosphorylase is encoded by a gene that has been alternatively designated glgY or glgP, which is located distal to glgA within the glgCAY operon (27, 37) . A second enzyme that is believed to be important for the metabolism of intracellular glycogen in E. coli is the glycogen debranching enzyme (EC 3.2.1.-), which hydrolyzes the ␣-1,6 branches of glycogen which has first been partially depolymerized by phosphorylase (11) . The glgBX operon is located upstream from and in tandem with glgCAY and includes the gene for glycogen branching enzyme (glgB [3] ) and possibly the gene for glycogen debranching enzyme or another catabolic glucanase (27) . This was previously hypothesized on the basis of the similarity of the deduced amino acid sequence of GlgX to sequences of glucanotransferases and hydrolases and the fact that glgX was not required for glucan biosynthesis (27) . Finally, the genes encoding two ␣-amylases, malS (31) and amyA (23) , have also been characterized for E. coli. However, malS is part of the maltose regulon, its gene product is not synthesized in glucose-grown cells, and it is a periplasmic enzyme. Therefore, MalS is believed not to be involved in metabolism of endogenous glycogen; the physiological function of AmyA has not been tested.
The results of the current study establish an expanded role for csrA in the genetic regulation of both synthesis of glycogen and its degradation. Furthermore, the previously identified glgX open reading frame is now shown to encode the glycogen debranching enzyme. Thus, structural genes needed for glycogen synthesis and catabolism are clustered together in two adjacent operons. The first contains genes required for the synthesis and for the hydrolysis of the ␣-1,6 linkages of glycogen; the second operon includes the genes required for the formation and for the depolymerization of the ␣-1,4-glucan linkages of the polymer.
(Some of the experiments described herein were conducted in partial fulfillment of the requirements for a Master of Science degree by H. Yang at the University of North Texas Health Science Center at Fort Worth.) ). All other biochemical reagents were purchased from commercial sources and were of the highest quality available.
MATERIALS AND METHODS

Chemicals
Bacterial strains, plasmids, and growth conditions. Table 1 lists the strains and plasmids that were used in this study, their sources, and relevant genotypes. For experimental determination of glycogen and glycogen-metabolizing enzymes and for genetic expression studies, strains were cultured as previously described (26) , with vigorous aeration at 37ЊC in a medium which allows optimal glycogen biosynthesis, Kornberg medium (1.1% K 2 HPO 4 , 0.85% KH 2 PO 4 , 0.6% yeast extract containing either glucose or maltose at 0.5%). Media were supplemented with the following compounds as required: ampicillin, 100 g/ml; tetracycline, 10 g/ml; kanamycin, 100 g/ml; diaminopimelic acid, 50 g/ml; X-Gal, 40 g/ml; IPTG, 5 mM.
Molecular biology and genetic techniques. Transduction of the TR1-5 allele (csrA::kanR) with P1vir was conducted (17) by using previously described selection and screening procedures (26) . Standard procedures were used for isolation of plasmid DNA and restriction fragments, restriction mapping, transformation, and molecular cloning (1) . DNA sequencing was conducted by the chain termination method of Sanger et al. (30) by using the Sequenase version 2.0 kit under the conditions suggested by the manufacturer (U.S. Biochemical Corp.). A plasmid which encodes a glgCAY::lacZ translational fusion, pYZ9, was obtained by ligating a gel-purified 3.7-kb HpaI restriction fragment of pOP12 into the (alkaline phosphatase-treated) SmaI site of pMLB1034 and transforming DH5␣ to ampicillin resistance. Blue colonies were isolated on LB medium (17) containing ampicillin and X-Gal. The fusion was verified by restriction enzyme mapping and sequencing across the glgY::lacZ junction by using a primer that anneals within lacZ (GATGTGCTGCAAGGCGATTAAGTTGGGTAACG). A 2.3-kb KpnI restriction fragment of pOP12 (19) was subcloned into the (alkaline phosphatase-treated) KpnI site of pUC19 to generate two plasmid clones, pBX49 and pBX31, which contained the glgX open reading frame oriented either in the same direction as lacZ of the pUC19 vector or in the opposite direction, respectively.
S-30-coupled transcription-translation. Experiments to measure the effects of the CsrA gene product on in vitro expression from the plasmid pYZ9 (encoding glgCAY::lacZ) were conducted in S-30 extracts prepared from strain TR-1-5BW3414 (csrA::kanR), as previously described (26) . The biologically active CsrA gene product used in these studies was expressed in a recombinant form which contains six histidine residues at the carboxy terminus, which allowed its purification to electrophoretic homogeneity by affinity chromatography on Ni 2ϩ -nitrilotriacetic acid resin (as described by the supplier, Qiagen, Inc., Chatsworth, Calif.) (15) .
Assays for enzyme activities, glycogen, and total protein. ␤-Galactosidase, glycogen, and total cell protein were determined as previously described (26) . Glycogen phosphorylase and maltodextrin phosphorylase activities were measured by monitoring the rate of incorporation of [ (14), since the E. coli debranching enzyme exhibits low-level activity on native glycogen. The assay conditions were previously found to be specific for the debranching enzyme, and other E. coli glucanases such as ␣-amylase did not influence debranching enzyme determinations (11) . A unit of debranching enzyme activity releases 1 nmol of reducing end groups (18) per min at 37ЊC. Control experiments were conducted with heat-inactivated extracts to assure that endogenous glycogen or other factors did not influence the reported activity values of phosphorylase or debranching enzyme, and the assays were determined within the linear range of enzyme activity.
RESULTS AND DISCUSSION
Effects of csrA on endogenous glycogen accumulation and metabolism. Figure 1 quantitatively compares glycogen accumulation levels in isogenic csrA ϩ and csrA::kanR strains throughout the growth curve and into the stationary phase and shows that accumulation reached a level of 1.6 mg/ml of protein in the csrA::kanR strain, or approximately 50% of the dry weight. The rate of net glycogen accumulation in this strain in (26) . Thus, both the rate of synthesis of glycogen and its subsequent utilization appeared to be negatively controlled via csrA. Regulation of the glycogen biosynthetic genes glgA and glgS via csrA. We had previously shown that the expression of glgC and glgB was negatively regulated via csrA (26) . In order to determine whether the expression of the other glycogen biosynthetic genes is affected by csrA, chromosomally encoded glgA::lacZ and glgS::lacZ translational fusions were tested for expression in csrA ϩ and csrA::kanR strains. Figure 2 shows that the expression levels of these two gene fusions in cells grown in Kornberg medium were approximately 12-fold and 3-fold higher in the csrA::kanR strains, respectively. Thus, the rapid accumulation of glycogen in the csrA::kanR mutant may be attributed to the fact that csrA negatively affects the expression of all of the glycogen biosynthetic genes, glgB, glgC, glgA, and glgS, which are located in three different operons, glgBX, glgCAY, and glgS.
Effects of csrA on the expression of glycogen phosphorylase. To test whether the rapid catabolism of glycogen in the csrA::kanR strain subsequent to its accumulation ( Fig. 1) was caused by effects of csrA on the expression of genes involved in glycogen catabolism, we first determined the specific activity of the key enzyme glycogen phosphorylase in csrA ϩ and csrA::kanR strains. E. coli synthesizes two glucan phosphorylases, one of which, glycogen phosphorylase, shows a substrate preference for native glycogen over short maltodextrins and is the glgY gene product (27, 37) . The other glucan phosphorylase, maltodextrin phosphorylase (EC 2.4.1.1), exhibits a substrate preference for maltodextrins over native glycogen, and its structural gene malP is expressed as one of the genes of the maltose regulon, which are induced by growth on maltose (33) . Glycogen phosphorylase is thus involved in the metabolism of endogenous glycogen, while maltodextrin phosphorylase is not (5, 6). Table 2 shows glucan phosphorylase specific activities present in eight strains of E. coli during the stationary phase, assayed in the presence of either glycogen (the preferred substrate of glycogen phosphorylase) or maltodextrin (the preferred substrate of maltodextrin phosphorylase). Experiments with strains which lack maltodextrin phosphorylase showed that glycogen phosphorylase activity was elevated three-to four-fold by the disruption of csrA. Glycogen phosphorylase specific activity was determined throughout the growth curve in the malP mutant strains G6MP11 (csrA (csrA::kanR) (Fig. 3) and was found to be induced in the stationary phase and negatively controlled via csrA. As expected, growth on maltose resulted in very strong induction of maltodextrin phosphorylase activity. This activity was found to exhibit a weak but reproducible positive effect of csrA (Table 2) . Finally, deletion of the region of the chromosome which contains both glgY and malP (in strains G6MD3 and TR1-5G6MD3) resulted in undetectable glucan phosphorylase activity of either kind (Table 2 ), in support of the existing genetic assignments.
In order to determine whether the effects of csrA on glycogen phosphorylase specific activity (Fig. 3) were mediated at the level of genetic expression, a plasmid-encoded glgCAY::lacZ translational fusion, pYZ9, was constructed and its expression was tested in vivo in the isogenic strains BW3414 (csrA ϩ ) and TR1-5BW3414 (csrA::kanR). Up to threefoldhigher levels of expression of this fusion in the csrA::kanR mutant TR1-5BW3414 than in the isogenic strain BW3414 (data not shown) were obtained, a result which was in agreement with results of the glycogen phosphorylase assays and further indicated that csrA negatively affects the expression of glgY. To determine whether the expression of this glgY::lacZ fusion was under the direct control of the CsrA gene product, its transcription-translation was tested in S-30 extracts prepared from TR1-5BW3414 (csrA::kanR) in either the presence or the absence of affinity-purified recombinant CsrA. Figure 4 shows that the expression of the glgY::lacZ fusion and the glgC and glgA genes (which were previously shown to be regulated via CsrA in vitro [26] ) was potently and specifically inhibited by CsrA.
These results support our previous hypothesis that the location of glgY within the glgCAY operon facilitates the coordinate genetic regulation of glycogen biosynthesis and catabolism (27) . a Cultures were grown for 18 h in Kornberg medium containing either 0.5% glucose or maltose and were tested for glucan phosphorylase activity by using either glycogen or maltodextrin as the glucose acceptor.
Expression of glycogen debranching enzyme, the GlgX gene product. The glycogen debranching enzyme is a second enzyme which has been reported to be involved in glycogen catabolism (11) . When glycogen debranching enzyme activity in csrA ϩ and csrA::kanR strains was tested, no significant difference was observed ( Table 3 ), indicating that csrA does not affect the expression of the debranching enzyme. Perhaps the relatively lower number of ␣-1,6 linkages (approximately 10% relative to the ␣-1,4 linkages), which are the substrate for the glycogen debranching enzyme, and the lower rate of glycogen catabolism relative to synthesis in E. coli do not require glgX to be regulated by factors such as CsrA, which modulate the expression of the other glg genes.
The structural gene which encodes debranching enzyme had not been previously mapped or cloned. Interestingly, we found that strains which lack the region of the chromosome which contains the glg gene cluster (G6MD3 and TR1-5G6MD3) did not express detectable levels of glycogen debranching enzyme (Table 3 ). This suggested that the debranching enzyme may be encoded by glgX, the one remaining unassigned open reading frame within the glg gene cluster. When glgX was cloned into the multiple cloning site of pUC19 in each orientation with respect to the lacZ promoter, the resulting plasmids caused glycogen debranching activity to be expressed at extremely high levels in G6MD3 (Table 3 ). The level of debranching activity from plasmid pBX49, in which the lacZ promoter of the vector is oriented to drive transcription of glgX, was significantly higher than that of pBX31, and only the activity from pBX49 was inducible by IPTG. On the basis of its previously determined specific activity (11), debranching enzyme represents approximately 3% of the total protein in the strain containing pBX49. As was expected for the E. coli debranching enzyme, less than 6% of the activity seen to occur on phosphorylase limit dextrin was observed when glycogen was used as a substrate (data not shown). Taken together with the known sequence homology of GlgX to glucanases (27) , these results indicate that glgX encodes the E. coli glycogen debranching enzyme.
Conclusions. During growth, glycogen is synthesized at the time when a nutrient such as nitrogen becomes scarce but a carbon source remains available. The present study provides the first evidence that the localization of biosynthetic and catabolic genes within the two tandem operons of the E. coli glg gene cluster, glgBX and glgCAY, facilitates the coordinate genetic expression of enzymes involved in glycogen biosynthesis and catabolism. This coordinate expression may permit the bacterium to prepare for impending starvation by expressing the important catabolic enzyme glycogen phosphorylase (GlgY), along with glycogen synthase and ADPglucose pyrophosphorylase, in the early stationary phase, before biosynthetic precursors for protein synthesis have been expended. The mechanism by which CsrA negatively regulates glgY expression is not precisely known. CsrA is an RNA-binding protein which is necessary for the predominant decay pathway of glgC mRNA (16) , and mobility shift data show that CsrA interacts specifically with the 5Ј region of this message (15) . If the polycistronic glgCAY transcript is not segmentally processed, regulation of glgY expression by CsrA may be accomplished quite simply through the net 5Ј-to-3Ј decay of this transcript. We are currently attempting to elucidate the details of this unconventional mechanism of genetic regulation and to further define the role of CsrA in modulating the metabolism and physiological properties of bacteria. a Cultures were grown in Kornberg medium containing 0.5% glucose and harvested at 18 h for determination of glycogen debranching enzyme activity.
